Investment Announcements

See all news

Disclaimer: Press releases prior to November 4, 2022, are provided for informational purposes only. [category buttons]

June 6, 2023

DW Healthcare Partners Invests in LKC

DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announces the completion of its investment in LKC Technologies, Inc. (“LKC”, or the “Company”).

January 3, 2023

DW Healthcare Partners Invests in Med Learning Group

DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announces the completion of its investment in Med Learning Group, LLC (“MLG”, or the “Company”). MLG, previously a division of Ultimate Medical Academy, is a full-service medical education company that holds an Accreditation with ACCME. MLG focuses on developing, implementing, and measuring online and in-person continuing education that improves healthcare practitioners’ ability to provide optimal care to patients.

August 30, 2022

DW Healthcare Partners Announces Sale of Med-Pharmex to Dechra Pharmaceuticals PLC

DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announced the closing of its sale of Med-Pharmex Holdings, Inc (“Med-Pharmex”, or the “Company”) to Dechra Pharmaceuticals PLC (“Dechra”). Med-Pharmex is a leading, fully-integrated veterinary pharmaceutical manufacturer focused on developing, manufacturing, and commercializing animal health drugs.

January 10, 2022

DW Healthcare Partners Invests in Vets Plus

DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announced the completion of its investment in Vets Plus, Inc and Noble Pharma, LLC (“Vets Plus “, “Noble”, or the “Company”).

December 6, 2021

DW Healthcare Partners Announces Sale of WillowWood to Blue Sea Capital

DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announced today the closing of its sale of WillowWood Global LLC (“WillowWood” or “the Company”) to Blue Sea Capital. WillowWood, a portfolio company of DW Healthcare Partners, is a leading designer and manufacturer of a broad range of prosthetic products.

October 13, 2021

DW Healthcare Partners announces Sale of Pentec Health

DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announced today that it has sold its minority interest in Pentec Health, a leading national provider of specialty infusion services to patients who require access to complex pharmaceutical products and services outside of the hospital setting, to Wellspring Capital Management.

July 27, 2021

DW Healthcare Partners Invests in Bio Agri Mix

DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announced the completion of its investment in Bio Agri Mix, LP (“Bio Agri Mix” or the “Company”).

May 5, 2021

Linden and DW Healthcare Partners Complete HydraFacial’s Public Offering via SPAC Merger

Linden Capital Partners (“Linden”) and DW Healthcare Partners IV, LP (“DW Healthcare Partners”), both private equity firms focused exclusively on the healthcare sector, announced today the completion of the merger of Edge Systems, LLC (“HydraFacial”), a category-creating beauty health company, with Vesper Healthcare Acquisition Corp. (NASDAQ: VSPR) (“Vesper” or “Vesper Healthcare”).

February 1, 2021

DW Healthcare Partners Invests in Parnell

DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announced the completion of its investment in Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF) (“Parnell” or the “Company”).